474
Views
71
CrossRef citations to date
0
Altmetric
Original Articles

Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization and predictors of mortality: a retrospective study

, , , , , , & show all

References

  • Han SH. Review of hepatic abscess from Klebsiella pneumoniaeAn association with diabetes mellitus and septic endophthalmitis. West J Med. 1995;162:220–4.
  • Ahmad TA, Haroun M, Hussein AA, El Ashry el SH, El-Sayed LH. Development of a new trend conjugate vaccine for the prevention of Klebsiella pneumoniae. Infect Dis Rep. 2012;4:e33.
  • Neuhauser MM, Weinstein RA, Rydman R, Danziger LH, Karam G, Quinn JP. Antibiotic resistance among gram-negative bacilli in us intensive care units: implications for fluoroquinolone use. JAMA. 2003;289:885–8.
  • Orsi GB, Garcia-Fernandez A, Giordano A, Venditti C, Bencardino A, Gianfreda R, et al. Risk factors and clinical significance of ertapenem-resistant Klebsiella pneumoniae in hospitalised patients. J Hosp Infect. 2011;78:54–8.
  • Won SY, Munoz-Price LS, Lolans K, Hota B, Weinstein RA, Hayden MK. Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing enterobacteriaceae. Clin Infect Dis. 2011;53:532–40.
  • Hussein K, Raz-Pasteur A, Finkelstein R, Neuberger A, Shachor-Meyouhas Y, Oren I, et al. Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae. J Hosp Infect. 2013;83:307–13.
  • MacKenzie FM, Forbes KJ, Dorai-John T, Amyes SG, Gould IM. Emergence of a carbapenem-resistant Klebsiella pneumoniae. Lancet. 1997;350:783.
  • Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, et al. Novel carbapenem-hydrolyzing beta-lactamase, kpc-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2001;45:1151–61.
  • Kitchel B, Rasheed JK, Patel JB, Srinivasan A, Navon-Venezia S, Carmeli Y, et al. Molecular epidemiology of kpc-producing Klebsiella pneumoniae isolates in the united states: clonal expansion of multilocus sequence type 258. Antimicrob Agents Chemother. 2009;53:3365–70.
  • Rogers BA, Aminzadeh Z, Hayashi Y, Paterson DL. Country-to-country transfer of patients and the risk of multi-resistant bacterial infection. Clin Infect Dis. 2011;53:49–56.
  • Jean S-S, Hsueh P-R. High burden of antimicrobial resistance in asia. Int J Antimicrob Agents. 2011;37:291–5.
  • Kofteridis DP, Valachis A, Dimopoulou D, Maraki S, Christidou A, Mantadakis E, et al. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization: a case-case-control study. J Infect Chemother. 2014;20:293–7.
  • Borer A, Saidel-Odes L, Eskira S, Nativ R, Riesenberg K, Livshiz-Riven I, et al. Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae. Am J Infect Control. 2012;40:421–5.
  • Nguyen M, Eschenauer GA, Bryan M, O'Neil K, Furuya EY, Della-Latta P, et al. Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes. Diagn Microbiol Infect Dis. 2010;67:180–4.
  • Orsi GB, Venditti M. Carbapenem-resistant Klebsiella pneumoniae transmission associated to endoscopy. Am J Infect Control. 2013;41:849–50.
  • Kotlovsky T, Shalginov R, Austin L, Sprecher H. Rapid detection of bla KPC-positive Klebsiella pneumoniae in a clinical setting. Eur J Clin Microbiol Infect Dis. 2009;28:309–11.
  • Anderson K, Lonsway D, Rasheed J, Biddle J, Jensen B, McDougal L, et al. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in enterobacteriaceae. J Clin Microbiol. 2007;45:2723–5.
  • Wikler MA. Performance standards for antimicrobial susceptibility testing: seventeenth informational supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2007.
  • Cockerill FR. Performance standards for antimicrobial susceptibility testing: twenty-first informational supplement. Wayne, PA: Clinical and Laboratory Standards Institute (CLSI); 2011.
  • Tenover FC, Kalsi RK, Williams PP, Carey RB, Stocker S, Lonsway D, et al. Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing. Emer Infect Dis. 2006;12:1209.
  • Gregory CJ, Llata E, Stine N, Gould C, Santiago LM, Vazquez GJ, et al. Outbreak of carbapenem-resistant Klebsiella pneumoniae in puerto rico associated with a novel carbapenemase variant. Infect Control Hosp Epidemiol. 2010;31:476–84.
  • Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother. 2008;52:1028–33.
  • Zavascki AP, Cruz RP, Goldani LZ. Risk factors for imipenem-resistant Pseudomonas aeruginosa: a comparative analysis of two case-control studies in hospitalized patients. J Hosp Infect. 2005;59:96–101.
  • Lee SO, Kim NJ, Choi SH, Hyong Kim T, Chung JW, Woo JH, et al. Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study. Antimicrob Agents. Chemother. 2004;48:224–8.
  • Kwak YG, Choi SH, Choo EJ, Chung JW, Jeong JY, Kim NJ, et al. Risk factors for the acquisition of carbapenem-resistant Klebsiella pneumoniae among hospitalized patients. Microb Drug Resist. 2005;11:165–9.
  • Gasink LB, Edelstein PH, Lautenbach E, Synnestvedt M, Fishman NO. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. Pneumoniae. Infect Control Hosp Epidemiol. 2009;30:1180–5.
  • Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol. 2008;29:1099–106.
  • Orsi G, Bencardino A, Vena A, Carattoli A, Venditti C, Falcone M, et al. Patient risk factors for outer membrane permeability and KPC-producing carbapenem-resistant Klebsiella pneumoniae isolation: results of a double case – control study. Infection. 2013;41:61–7.
  • Gomez Rueda V, Zuleta Tobon JJ. Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae: a case-case-control study. Colomb Med (Cali). 2014;45:54–60.
  • Falagas ME, Rafailidis PI, Kofteridis D, Virtzili S, Chelvatzoglou FC, Papaioannou V, et al. Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study. J Antimicrob Chemother. 2007;60:1124–30.
  • Wu D, Cai J, Liu J. Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae. South Med J. 2011;104:106–10.
  • Deshpande LM, Fritsche TR, Moet GJ, Biedenbach DJ, Jones RN. Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from north america and europe: a report from the sentry antimicrobial surveillance program. Diagn Microbiol Infect Dis. 2007;58:163–70.
  • Meakins S, Fisher IS, Berghold C, Gerner-Smidt P, Tschape H, Cormican M, et al. Antimicrobial drug resistance in human nontyphoidal salmonella isolates in europe 2000-2004: a report from the enter-net international surveillance network. Microb Drug Resist. 2008;14:31–5.
  • Mavroidi A, Neonakis I, Liakopoulos A, Papaioannou A, Ntala M, Tryposkiadis F, et al. Detection of citrobacter koseri carrying beta-lactamase KPC-2 in a hospitalised patient, Greece. Euro Surveill. 2011;16:2011.
  • Landman D, Bratu S, Quale J. Contribution of ompk36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae. J Med Microbiol. 2009;58:1303–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.